SCHEMBL6402672

SCHEMBL6402672

Cc1ccc(-c2nnc(SC(C)C(=O)O)n2-c2ccc(C)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 3/20 0.57
PKM P14618 1/20 0.57
ALOX15 P16050 3/20 0.54
TSHR P16473 3/20 0.54
HPGD P15428 2/20 0.54
HSD17B10 Q99714 2/20 0.54
KDM4E B2RXH2 2/20 0.54
ALDH1A1 P00352 2/20 0.54
POLB P06746 2/20 0.54
MCL1 Q07820 1/20 0.54
RXFP1 Q9HBX9 1/20 0.54
MAPK1 P28482 1/20 0.54
MAPT P10636 1/20 0.50
ALPG P10696 2/20 0.49
LMNA P02545 1/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CDC25A P30304 2/20 0.47
CDC25B P30305 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6407969 0.86 HPGD (0.73) PKMALOX15TSHRHPGDHSD17B10
SCHEMBL6406153 0.83 HPGD (0.58) PKMTSHRHPGDALDH1A1MAPK1
SCHEMBL6406110 0.78 HPGD (0.73) PKMTSHRHPGDHSD17B10ALDH1A1
SCHEMBL6411001 0.77 HTT (0.67) PKMALOX15TSHRHSD17B10MAPT
SCHEMBL6412224 0.75 PKM (0.92) PKMALDH1A1POLBLMNAL3MBTL1
SCHEMBL6403869 0.75 KMT2A (0.71) ALOX15TSHRHPGDHSD17B10KDM4E
SCHEMBL23527350 0.74 ALPG (0.52) PKMALOX15TSHRHPGDKDM4E
SCHEMBL22018952 0.74 MAPT (0.60) ALOX15TSHRHPGDHSD17B10ALDH1A1
SCHEMBL6403317 0.73 PKM (1.00) PKMHPGDHSD17B10ALDH1A1MAPK1
SCHEMBL5338687 0.72 MAPT (0.76) PKMHPGDALDH1A1RXFP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT DGAT1 1274/4885PKM 2155/4885ALOX15 2151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.